CLINICAL_TRIALS
trial_result
· 2022-02-23
Clinical Trial Update: Study of Liposomal Annamycin for the Treatment of Subjects With Acute Myeloid Leukemia (AML) [Phase 1, Phase 2]
Summary
A Phase 1/2 study evaluating liposomal annamycin for acute myeloid leukemia has completed with results posted in 2022.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Moleculin Biotech, Inc. | Conditions: Leukemia, Myeloid, Acute | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2022-02-23